PRICE T ROWE ASSOCIATES INC /MD/ - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 89 filers reported holding CARDIFF ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$51
-5.6%
36,5000.0%0.00%
Q2 2023$54
-11.5%
36,5000.0%0.00%
Q1 2023$61
+19.6%
36,5000.0%0.00%
Q4 2022$51
-99.9%
36,5000.0%0.00%
Q3 2022$57,000
-28.8%
36,5000.0%0.00%
Q2 2022$80,000
+50.9%
36,500
+69.9%
0.00%
Q1 2022$53,000
-57.3%
21,480
+3.9%
0.00%
Q4 2021$124,000
-98.7%
20,680
-96.1%
0.00%
-100.0%
Q4 2020$9,528,000
+21.3%
529,627
-4.3%
0.00%0.0%
Q3 2020$7,852,000553,3590.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders